Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China flag China · Delayed Price · Currency is CNY
25.02
-0.94 (-3.62%)
May 12, 2026, 3:04 PM CST

Wuhan Hvsen Biotechnology Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
5,0494,1791,6602,3643,3564,735
Market Cap Growth
6.39%151.73%-29.79%-29.56%-29.11%7.30%
Enterprise Value
4,7944,0072,0882,5963,2644,405
Last Close Price
25.0220.739.9714.0419.4526.69
PE Ratio
17.6616.51-140.8963.6835.64
Forward PE
22.1420.5320.9630.44--
PS Ratio
2.902.491.382.323.284.75
PB Ratio
2.231.911.131.572.182.93
P/TBV Ratio
2.352.031.241.682.343.14
P/FCF Ratio
48.7729.53----
P/OCF Ratio
21.6617.5238.1325.4434.7230.41
EV/Sales Ratio
2.752.381.742.553.194.42
EV/EBITDA Ratio
10.7810.0215.8720.4526.4126.89
EV/EBIT Ratio
14.8514.34113.82395.1653.5032.56
EV/FCF Ratio
46.3128.31----
Debt / Equity Ratio
0.150.110.610.560.510.42
Debt / EBITDA Ratio
0.770.576.756.636.404.16
Debt / FCF Ratio
3.301.62----
Net Debt / Equity Ratio
-0.12-0.110.250.160.00-0.26
Net Debt / EBITDA Ratio
-0.60-0.602.751.930.04-2.55
Net Debt / FCF Ratio
-2.59-1.71-2.39-2.67-0.010.94
Asset Turnover
0.550.560.400.340.360.44
Inventory Turnover
4.454.514.223.783.724.06
Quick Ratio
1.501.291.081.251.422.70
Current Ratio
1.931.771.421.621.683.18
Return on Equity (ROE)
14.89%13.88%-1.33%1.10%3.34%8.86%
Return on Assets (ROA)
6.41%5.80%0.38%0.14%1.33%3.76%
Return on Invested Capital (ROIC)
14.44%13.02%1.03%0.40%4.13%12.73%
Return on Capital Employed (ROCE)
13.10%12.30%0.90%0.30%2.80%6.00%
Earnings Yield
5.67%6.06%-1.21%0.71%1.57%2.81%
FCF Yield
2.05%3.39%-9.09%-3.87%-9.90%-9.39%
Dividend Yield
1.54%1.45%1.07%1.92%1.54%1.24%
Payout Ratio
17.08%19.72%-349.40%118.55%36.08%
Buyback Yield / Dilution
-19.57%-18.13%0.06%-0.33%0.19%-12.59%
Total Shareholder Return
-18.01%-16.69%1.12%1.59%1.74%-11.35%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.